Shanghai Henlius Biotech Inc
HKEX:2696
Wall Street
Price Targets
Price Targets Summary
Shanghai Henlius Biotech Inc
According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 100.52 HKD with a low forecast of 95.95 HKD and a high forecast of 108.06 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Henlius Biotech Inc's stock price target?
Price Target
100.52
HKD
According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 100.52 HKD with a low forecast of 95.95 HKD and a high forecast of 108.06 HKD.
What is Shanghai Henlius Biotech Inc's Revenue forecast?
Projected CAGR
3%
For the last 6 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 203%. The projected CAGR for the next 3 years is 3%.
What is Shanghai Henlius Biotech Inc's Operating Income forecast?
Projected CAGR
2%
The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 2%.
What is Shanghai Henlius Biotech Inc's Net Income forecast?
Projected CAGR
3%
The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 3%.